Charles River

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 

CEO
Birgit Girshick
CEOBirgit Girshick
Employees
19,700
Employees19,700
Headquarters
Wilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded
1947
Founded1947
Employees
19,700
Employees19,700

CRL Key Statistics

Market cap
13.27B
Market cap13.27B
Price-Earnings ratio
-57.31
Price-Earnings ratio-57.31
Dividend yield
Dividend yield
Average volume
946.42K
Average volume946.42K
High today
$283.00
High today$283.00
Low today
$276.00
Low today$276.00
Open price
$280.70
Open price$280.70
Volume
1.36M
Volume1.36M
52 Week high
$303.31
52 Week high$303.31
52 Week low
$144.26
52 Week low$144.26

Stock Snapshot

The current Charles River(CRL) stock price is $278.06, with a market capitalization of 13.27B. The stock trades at a price-to-earnings (P/E) ratio of -57.31.

As of 2026-09-20, Charles River(CRL) stock has fluctuated between $276.00 and $283.00. The current price stands at $278.06, placing the stock +0.7% above today's low and -1.7% off the high.

Charles River(CRL) shares are trading with a volume of 1.36M, against a daily average of 946.42K.

In the last year, Charles River(CRL) shares hit a 52-week high of $303.31 and a 52-week low of $144.26.

In the last year, Charles River(CRL) shares hit a 52-week high of $303.31 and a 52-week low of $144.26.

CRL News

Simply Wall St 2d
Will Rapid Cell Banking Change Charles River Stock Narrative - simplywall.st

...

Will Rapid Cell Banking Change Charles River Stock Narrative - simplywall.st
TipRanks 3d
Charles River introduces rapid cell banking programs to reduce timelines

Charles River (CRL) Laboratories International has introduced rapid cell banking programs designed to significantly accelerate release timelines, enabling bioph...

Simply Wall St 5d
Charles River Laboratories International Automation Push Puts Valuation Back In Focus

Charles River Laboratories International (CRL) just put its Endosafe Cartridge Technology Automated Manufacturing Suite into full swing, with automation now dri...

Charles River Laboratories International Automation Push Puts Valuation Back In Focus

Analyst ratings

68%

of 19 ratings
Buy
68.4%
Hold
21.1%
Sell
10.5%

More CRL News

TipRanks 5d
Charles River Labs: Buy Rating Reaffirmed on Improving Fundamentals, AI Tailwinds, and Unchanged $300 Price Target

Morgan Stanley analyst Kallum Titchmarsh maintained a Buy rating on Charles River Labs yesterday and set a price target of $300.00. Kallum Titchmarsh has given...

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.